Mode
Text Size
Log in / Sign up

Cross-sectional study finds association between autoimmune thyroiditis and rheumatoid arthritis

Cross-sectional study finds association between autoimmune thyroiditis and rheumatoid arthritis
Photo by National Cancer Institute / Unsplash
Key Takeaway
Note cross-sectional association between autoimmune thyroiditis and RA; causal inference is precluded.

This cross-sectional observational study examined the association between autoimmune thyroiditis (AIT) and rheumatoid arthritis (RA) using two cohorts: a nationally representative sample from NHANES 2007–2012 (n=5,715) and an independent hospital-based clinical cohort from China (n=196). After multivariable adjustment, AIT was significantly associated with prevalent RA, though specific effect sizes and absolute numbers were not reported. The study also explored potential mediators of this association.

In the NHANES cohort, uric acid accounted for 13.4% of the observed association between AIT and RA, with directionally consistent findings in the external cohort. Free triiodothyronine (FT3) demonstrated inconsistent and non-significant mediation across both cohorts. A risk stratification nomogram for RA status among individuals with AIT showed good discriminative performance, with an area under the curve (AUC) of 0.776 in NHANES and 0.724 in the external validation cohort.

Safety and tolerability data were not reported. The primary limitation is the cross-sectional design, which precludes causal inference. The authors note the findings suggest shared metabolic and endocrine contexts between AIT and RA but emphasize that the clinical application of the risk model and generalizability of the FT3 mediation findings should not be overstated. These results support the need for longitudinal investigation to establish temporal relationships and potential causality.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundAutoimmune thyroiditis (AIT) frequently coexists with other autoimmune diseases, suggesting shared pathophysiological pathways. However, large-scale evidence supporting the relationship between AIT and rheumatoid arthritis (RA), as well as the potential metabolic and endocrine mediators linking the two, remains limited.MethodsA cross-sectional analysis was conducted using nationally representative data from NHANES 2007–2012 (n = 5,715). Multivariable logistic regression models were used to evaluate associations between AIT and RA. Mediation analyses assessed the potential indirect effects of uric acid and free triiodothyronine (FT3). A cross-sectional risk stratification nomogram for RA status among individuals with AIT was constructed. Model performance was assessed in NHANES and examined for consistency in an independent hospital-based clinical cohort from China (n = 196).ResultsAIT was significantly associated with prevalent RA in the NHANES cohort after multivariable adjustment. Uric acid and FT3 were statistically associated with both AIT and RA in regression analyses. Exploratory mediation analyses suggested that uric acid accounted for a modest proportion of the observed association in NHANES (13.4%), with directionally consistent findings in the external clinical cohort, whereas FT3 demonstrated inconsistent and non-significant mediation across cohorts. The risk stratification model showed good discriminative performance in NHANES (AUC = 0.776) and maintained comparable discrimination in the external cohort (AUC = 0.724), with acceptable calibration.ConclusionsIn this cross-sectional study, AIT was associated with prevalent RA, and selected metabolic and endocrine biomarkers were statistically related to this association. Although causal inference is precluded by the study design, these findings suggest the presence of shared metabolic and endocrine contexts underlying thyroid and joint autoimmunity and support further longitudinal investigation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.